Back
Corvus Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
CRVS
Corvus Pharmaceuticals
Last Price:
8.94
Seasonality Move:
-3.9%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.53 | Buy |
| 20-day SMA: | 8.78 | Buy |
| 50-day SMA: | 7.1 | Buy |
| 200-day SMA: | 3.54 | Buy |
| 8-day EMA: | 8.6 | Buy |
| 20-day EMA: | 8.41 | Buy |
| 50-day EMA: | 7.24 | Buy |
| 200-day EMA: | 4.34 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 60.34 | Buy |
| Chaikin Money Flow: | 638494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.94 - 9.14) | Buy |
| Bollinger Bands (100): | (2.78 - 7.48) | Buy |
Corvus Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 8.94 while CRVS 8-day simple moving average is 8.53, which is a Buy signal.
- The stock price of CRVS is 8.94 while Corvus Pharmaceuticals 20-day SMA is 8.78, which makes it a Buy.
- Corvus Pharmaceuticals 50-day simple moving average is 7.10 while CRVS share price is 8.94, making it a Buy technically.
- CRVS stock price is 8.94 and Corvus Pharmaceuticals 200-day simple moving average is 3.54, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a Buy
The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
574.46M
Price in USD:
8.94
Share Volume:
815.56K
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.30
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?
The Corvus Pharmaceuticals stock price is 8.94 USD today. -
Will CRVS stock go up or go down?
Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Corvus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is not overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 8.94 while CRVS 8-day exponential moving average is 8.60, which is a Buy signal.
- The stock price of CRVS is 8.94 while Corvus Pharmaceuticals 20-day EMA is 8.41, which makes it a Buy.
- Corvus Pharmaceuticals 50-day exponential moving average is 7.24 while CRVS share price is 8.94, making it a Buy technically.
- CRVS stock price is 8.94 and Corvus Pharmaceuticals 200-day simple moving average is 4.34, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
- CRVS Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Corvus Pharmaceuticals is a Buy
- Corvus Pharmaceuticals Relative Strength Index (RSI) is 60.34, which suggest Corvus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Corvus Pharmaceuticals is (7.94 - 9.14), which suggest Corvus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Corvus Pharmaceuticals is (2.78 - 7.48), which suggest Corvus Pharmaceuticals is a Buy
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.